Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,789.00
Bid: 1,788.50
Ask: 1,789.00
Change: 11.00 (0.62%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,789.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Glaxo Joins CureVac To Fight Covid-19 Variants

Wed, 03rd Feb 2021 08:20

(Alliance News) - GlaxoSmithKline and German biopharmaceutical company CureVac on Wednesday announced a new EUR150 million collaboration to jointly develop next-generation mRNA vaccines for Covid-19, with the potential for a "multi-valent approach" to address multiple emerging variants in one vaccine.

Already approved vaccines from Pfizer and Moderna use the same mRNA technology that give instructions for the body's cells to make a harmless piece of "spike proteins". The spike protein is found on the surface of the virus that causes Covid-19. This in turn makes the body trigger an immune response, offering immunity against any potential future infections. However, Pfizer and Moderna's jabs have to be administered in two doses.

Under the terms of the collaboration agreement, Glaxo will have exclusive rights to develop, manufacture, and commercialise the vaccine in all countries with the exception of Germany, Austria and Switzerland. It also will be the marketing authorisation holder for all countries other than Switzerland. Glaxo will make an upfront payment to CureVac of EUR75 million and a further milestone payment of EUR75 million, conditional on the achievement of specific milestones.

Further, Glaxo will also support the manufacture of up to 100 million doses of CureVac's first generation Covid-19 vaccine candidate CVnCoV in 2021.

The pair will contribute resources and expertise to research, develop, and manufacture a number of novel mRNA vaccine candidates, including multi-valent and monovalent approaches. Glaxo said the aim is to offer broader protection against a variety of different SARS-CoV2 variants, and to enable a quick response to new variants potentially emerging in the future.

The development programme will begin immediately, with the target of introducing the vaccine in 2022, subject to regulatory approval, Glaxo noted.

GlaxoSmithKline will report annual results at midday on Wednesday.

The FTSE 100 stock was up 0.5% in early trade.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: up 0.7% at 6,560.27

----------

Hang Seng: up 0.2% at 29,307.46

Nikkei 225: closed up 1.0% at 28,646.50

DJIA: closed up 475.57 points, or 1.6%, at 30,687.48

S&P 500: closed up 1.4% at 3,826.31

----------

GBP: up at USD1.3651 (USD1.3644)

EUR: flat at USD1.2031 (USD1.2029)

Gold: firm at USD1,837.84 per ounce (USD1,837.20)

Oil (Brent): firm at USD57.90 a barrel (USD57.58)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Wednesday's Key Economic Events still to come

0930 GMT UK CIPS-Markit services purchasing managers' index

1100 GMT Ireland unemployment

0955 CET Germany services PMI

1000 CET EU services PMI

1100 CET EU euro area inflation

1100 CET EU producer price index

0700 EST US MBA weekly mortgage applications survey

0815 EST US ADP national employment report

0945 EST US services PMI

1000 EST US ISM services PMI

1030 EST US EIA weekly petroleum status report

----------

A new subsidy system to provide support for businesses will "propel the UK to the forefront of innovation and help create the jobs of the future", Business Secretary Kwasi Kwarteng said. The government minister announced plans for a long-term replacement to the EU's state aid regime, signalling a break away from Brussels' rules post-Brexit. It is hoped the new scheme will allow the UK to be more dynamic in helping businesses, and that it will encourage job creation and growth. Local authorities, public bodies and the devolved administrations will be able to decide if they can issue subsidies to businesses, following UK-wide principles, under the plans.

----------

The services sector in Ireland in January suffered its steepest drop-off in activity since the early months of the coronavirus pandemic. The AIB Ireland services business activity index fell to 36.2 points in January from the neutral score of 50.1 in December. The almost 14-point decline in the purchasing managers' index score was third-largest on record, behind only those seen in March and April last year. IHS Markit said the difficult start to 2021 for Irish service providers was due to tightened lockdown restrictions to combat the second wave of Covid-19. More positively, it said, employment was only fractionally lower, and the expectations of survey respondents for future activity were only slightly lower than in December. "The impact of the latest lockdown was very evident in a sharp fall-off in new business as the tightening of restrictions suppressed demand," commented AIB Chief Economist Oliver Mangan. "The decline was not as severe for new export business as most other countries have not implemented the same extensive lockdown seen in Ireland and the UK."

----------

Italy's president is expected Wednesday to ask former head of the European Central Bank Mario Draghi to take over as prime minister following the collapse of the coalition government in the coronavirus-ravaged country. President Sergio Mattarella turned to the ex-central banker after Italy's ruling parties were unable to form a new government in the wake of a split last month that saw prime minister Giuseppe Conte resign. Draghi, an Italian economist credited with saving the eurozone at the height of the debt crisis in 2012, would take over at a crucial time, with his country still battling a raging pandemic. Conte's centre-left coalition had been in power since September 2019 but was fatally weakened last month when former premier Matteo Renzi withdrew his Italia Viva party in a row over the handling of the Covid-19 pandemic.

----------

Japan's service sector remained at contraction levels in January, due to sharper declines in order and new business inflows, data from au Jibun bank and IHS Markit showed. The seasonally adjusted Japan services business activity index dipped to 46.1 index points in January from 47.7 points in December, marking the sharpest fall since August, and the 12th consecutive month of a drop in business activity. Panel members noted that the resurgence in Covid-19 cases and the introduction of a state of emergency to allow new restrictions that are for curbing the spread of the virus caused a fall in new work, while international demand declined further.

----------

BROKER RATING CHANGES

----------

MORGAN STANLEY RAISES AVIVA TO 'OVERWEIGHT' ('EQUAL-WEIGHT') - TARGET 425 (376) PENCE

----------

SOCGEN RAISES PRUDENTIAL TO 'HOLD' (SELL) - PRICE TARGET 1,250 (1,100) PENCE

----------

BARCLAYS RAISES PERSIMMON TO 'OVERWEIGHT' (EQUALWEIGHT) - TARGET 3,000 (2,800) PENCE

----------

COMPANIES - FTSE 100

----------

Vodafone Group reported a fall in third-quarter revenue and said its Vantage Towers IPO remains on track. For the third quarter ended December 31, total revenue was down 4.7% to EUR11.20 billion from EUR11.75 billion in the third quarter of 2019. Service revenue was down 3.9% to EUR9.36 billion from EUR9.73 billion. Vodafone said service revenue rose 0.4% on an organic basis. Vodafone reaffirmed its financial 2021 guidance with adjusted earnings before interest, tax, depreciation and amortisation expected to be between EUR14.4 billion to EUR14.6 billion and free cash flow of at least EUR5 billion. In fixed broadband, Vodafone said there has been strong demand for high-speed connectivity, with over 1.1 million next-generation network broadband customers added in Europe year-to-date, taking its total NGN broadband base to 22.6 million. "I am pleased the group returned to service revenue growth in Q3 as a result of the continued commercial momentum across our business, including our largest market Germany. Our good trading performance underscores our confidence in the outlook for the full year. We have made further progress on our strategic priorities, including the IPO of Vantage Towers in early 2021, which remains firmly on track and will now include our 50% shareholding in the UK towers joint venture with Telefonica," said Chief Executive Officer Nick Read.

----------

Ferguson said it is in the process of registering with the US Securities & Exchange Commission to enable trading of its ordinary shares in the US. Ferguson anticipates that the additional US listing will become effective in early March and confirmed that it has applied to list its ordinary shares on the New York Stock Exchange. In addition, Ferguson will retain its premium listing on the London Stock Exchange and inclusion in the FTSE 100 index. As a result of the additional US Listing, Ferguson's current American depositary receipt scheme managed by JPMorgan Chase Bank will be terminated.

----------

Miner and commodities trader Glencore reported declines in annual copper, cobalt and coal output but increases in the two precious metals, gold and silver. Copper production fell by 8% in 2020 to 1.26 million tonnes from 1.37 million, though Glencore said copper output was steady on 2019 when excluding Mutanda, which is currently on care and maintenance. Cobalt production dropped 41% to 27,400 ounces from 46,300 ounces, and coal by 24% to 106.2 million tonnes from 139.5 million in 2019. However, gold output rose by 3% to 916,000 ounces in 2020 from 886,000 and silver by 2% to 32.8 million ounces from 32.0 million. "Our mining assets performed well in difficult circumstances during 2020," said Chief Executive Officer Ivan Glasenberg. "Various precautionary operating changes made in Q2 continued into the second half, with sustainable and safe working practices embedded for the pandemic era. Production picked up accordingly, with year-over-year increases in zinc, gold and silver production."

----------

COMPANIES - GLOBAL

----------

Siemens said it has had an "outstanding start" to financial 2021, as a result of improving conditions in some of its businesses and geographic regions. The Munich, Germany-based industrial firm reported net income in it financial first quarter ended December 31 rose to EUR1.5 billion from EUR1.1 billion a year prior. Group-wide, orders increased by 15% on a comparable basis, excluding currency translation and portfolio effects, and revenue was up 7%, with all Industrial Businesses contributing to growth, Siemens said. As a result of the improved performance, Siemens said it expects financial 2021 net income to be between EUR5.0 billion and EUR5.5 billion, above the previous expectation of moderate growth compared to EUR4.2 billion in 2020.

----------

Banco Santander reported an improved performance in 2020, thanks to growing client demand. The Spanish lender said customer volumes grew in all regions in 2020, resulting in lending increase of 5% year-on-year, while demand deposits rose by 14%, as the number of loyal customers climbed to 22.8 million, up 6% on the prior year. Customer revenue totalled EUR42.01 billion for the year, stable annually in constant currency, on the back of growth in South America and a resilient performance in North America. The bank's common equity tier 1 ratio increased to 12.34% – above its target range of between 11% and 12%.

----------

Wednesday's Shareholder Meetings

Codemasters Group Holdings PLC - GM re takeover by Electronic Arts

Daily Mail & General Trust PLC - AGM

DP Eurasia NV - EGM re director appointment, Euroclear Nederland

Imperial Brands PLC- AGM

Premier Miton Group PLC - AGM

Stobart Group Ltd - GM re name change to Esken Ltd

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.